Artelo Biosciences Advances Psoriasis Treatment with ART26.12 Amid Market Volatility
Artelo Biosciences Inc. has made headlines with promising research on ART26.12, a potential treatment for psoriasis, amidst significant market activity and increased short interest in its stock.
3 minutes to read